The impact of the stress hyperglycemia ratio on mortality and rehospitalization rate in patients with acute decompensated heart failure and diabetes

[1]  J. Chen,et al.  Impact of the Stress Hyperglycemia Ratio on In-Hospital and Long-Term Poor Prognosis in Patients with Acute Myocarditis , 2023, Reviews in Cardiovascular Medicine.

[2]  H. Tian,et al.  'Stress hyperglycemia ratio and in-hospital prognosis in non-surgical patients with heart failure and type 2 diabetes , 2022, Cardiovascular Diabetology.

[3]  Z. Wang,et al.  The association between fibrinogen-to-albumin ratio (FAR) and adverse prognosis in patients with acute decompensated heart failure at different glucose metabolic states , 2022, Cardiovascular Diabetology.

[4]  Simiao Wu,et al.  The stress hyperglycemia ratio is associated with the development of cerebral edema and poor functional outcome in patients with acute cerebral infarction , 2022, Frontiers in Aging Neuroscience.

[5]  Akshay S. Desai,et al.  Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. , 2022, The New England journal of medicine.

[6]  Feng Chen,et al.  Novel cardioprotective mechanism for Empagliflozin in nondiabetic myocardial infarction with acute hyperglycemia. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[7]  Y. Shiraishi,et al.  Divergent effect of blood glucose dysregulation on long-term clinical outcome in acute decompensated heart failure: A reappraisal in contemporary practice. , 2022, International journal of cardiology.

[8]  Jingang Yang,et al.  Stress hyperglycemia ratio and long‐term mortality after acute myocardial infarction in patients with and without diabetes: A prospective, nationwide, and multicentre registry , 2022, Diabetes/metabolism research and reviews.

[9]  Zhonghai Wei,et al.  Prognostic value of triglyceride glucose (TyG) index in patients with acute decompensated heart failure , 2022, Cardiovascular Diabetology.

[10]  G. Fadini.  Perturbation of Glucose Homeostasis During Acute Illness: Stress Hyperglycemia and Relative Hypoglycemia. , 2022, Diabetes care.

[11]  R. Coronel,et al.  Direct cardiac effects of SGLT2 inhibitors , 2022, Cardiovascular Diabetology.

[12]  Sheyu Li,et al.  Visit-to-visit glycated hemoglobin A1c variability in adults with type 2 diabetes: a systematic review and meta-analysis , 2022, Chinese medical journal.

[13]  aguda y crónica,et al.  Comments on the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2022, Revista espanola de cardiologia.

[14]  Yitian Zheng,et al.  The Impact of the Stress Hyperglycemia Ratio on Short-term and Long-term Poor Prognosis in Patients With Acute Coronary Syndrome: Insight From a Large Cohort Study in Asia. , 2022, Diabetes care.

[15]  G. Sinagra,et al.  [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.

[16]  G. Llauradó,et al.  Prognostic Value of the Acute-to-Chronic Glycemic Ratio at Admission in Heart Failure: A Prospective Study , 2021, Journal of clinical medicine.

[17]  Neel S. Singhal,et al.  Diabetes, stroke, and neuroresilience: looking beyond hyperglycemia , 2021, Annals of the New York Academy of Sciences.

[18]  K. Bendjelid,et al.  Stress hyperglycemia, cardiac glucotoxicity, and critically ill patient outcomes current clinical and pathophysiological evidence , 2021, Physiological reports.

[19]  P. Rucci,et al.  Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA , 2020, Cardiovascular Diabetology.

[20]  G. Filippatos,et al.  SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials , 2020, The Lancet.

[21]  N. Chattipakorn,et al.  Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury , 2020, Cardiovascular Diabetology.

[22]  J. Butler,et al.  Acutely decompensated versus acute heart failure: two different entities , 2019, Heart Failure Reviews.

[23]  T. Guzik,et al.  Oxidative stress and inflammatory markers in prediabetes and diabetes. , 2019, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[24]  Hui Chen,et al.  Predictive Value of the Acute-to-Chronic Glycemic Ratio for In-Hospital Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention , 2019, Angiology.

[25]  M. Budoff,et al.  Atherosclerosis: Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation , 2019, Journal of diabetes.

[26]  Sheng-nan Wu,et al.  Hyperglycemia‐Driven Inhibition of AMP‐Activated Protein Kinase a2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria‐Associated Endoplasmic Reticulum Membranes in Vivo , 2019, The FASEB Journal.

[27]  F. Veglia,et al.  Prognostic Value of the Acute-to-Chronic Glycemic Ratio at Admission in Acute Myocardial Infarction: A Prospective Study , 2018, Diabetes Care.

[28]  C. Kodner,et al.  Glucose Management in Hospitalized Patients. , 2017, American family physician.

[29]  A. Armario,et al.  Psychostimulants and forced swim stress interaction: how activation of the hypothalamic-pituitary-adrenal axis and stress-induced hyperglycemia are affected , 2017, Psychopharmacology.

[30]  A. Armario,et al.  Psychostimulants and forced swim stress interaction: how activation of the hypothalamic-pituitary-adrenal axis and stress-induced hyperglycemia are affected , 2017, Psychopharmacology.

[31]  R. Gianchandani,et al.  Stress Hyperglycemia During Surgery and Anesthesia: Pathogenesis and Clinical Implications , 2016, Current Diabetes Reports.

[32]  J. Torres-Macho,et al.  First plasma glucose value after urgent admission and in-hospital mortality in acutely decompensated heart failure. , 2015, Heart & lung : the journal of critical care.

[33]  P. Marik,et al.  Stress hyperglycemia: an essential survival response! , 2013, Critical Care.

[34]  J. Foreman,et al.  The effects of hyperglycemia and endotoxemia on coagulation parameters in healthy adult horses. , 2013, Journal of veterinary internal medicine.

[35]  V. Gerdes,et al.  The Hemostatic System in Patients With Type 2 Diabetes With and Without Cardiovascular Disease , 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[36]  J H Devries,et al.  Hyperglycemia: a prothrombotic factor? , 2010, Journal of thrombosis and haemostasis : JTH.

[37]  B. Frier,et al.  Vascular disease and diabetes: is hypoglycaemia an aggravating factor? , 2008, Diabetes/metabolism research and reviews.

[38]  T. van der Poll,et al.  Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. , 2008, Blood.

[39]  P. Radermacher,et al.  Glucose metabolism and catecholamines , 2007, Critical care medicine.

[40]  G. Boden,et al.  Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation , 2007, Current diabetes reports.

[41]  T. van der Poll,et al.  Hyperglycemia Stimulates Coagulation, Whereas Hyperinsulinemia Impairs Fibrinolysis in Healthy Humans , 2006, Diabetes.

[42]  G. Davı̀,et al.  Platelet activation in type 2 diabetes mellitus , 2004, Journal of thrombosis and haemostasis : JTH.

[43]  B. Sobel,et al.  Effect of combination glipizide GITS/metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects. , 2002, Diabetes care.

[44]  B. Walker,et al.  Glucocorticoids and insulin resistance: old hormones, new targets. , 1999, Clinical science.

[45]  H. Chandalia,et al.  STRESS HYPERGLYCAEMIA , 1984, The Lancet.

[46]  Dhiren P. Shah,et al.  ON OXIDATIVE STRESS AND DIABETIC COMPLICATIONS , 2013 .

[47]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..